We are committed to convening and supporting partners advancing patient-centered, innovative, evidence-based solutions addressing this public health challenge.
Collaboration is key to ending the opioid crisis. Now more than ever, it is critical for us to think creatively, test new approaches, remove silos, and enhance and expand activities proven to prevent and reduce opioid use disorder.
We welcome the opportunity to explore partnerships and collaborate with all who are dedicated to furthering our goal of accelerating solutions to end this public health emergency.
FORE is a national grantmaking organization focused on ending the nation’s opioid crisis. We are deeply committed to enhancing access to care for all Americans experiencing an opioid use disorder and enabling communities to invest in prevention.
The cost of inaction is simply too high. Over 128 Americans die every day from opioid overdoses. Families are facing hardships while the resources of clinicians, first responders, and others are stretched thin. The stigma of addiction and shortage of evidence-based prevention and treatment options have left many without the help they need.
Our funding priorities are shaped by convening leaders in addiction medicine, pain management, public health, health policy, and health care delivery. I am grateful to those who have given their time to inform our efforts to help everyone affected by this public health emergency.
No single solution will solve this crisis. For this reason, we support patient-centered efforts that aim to achieve the following:
- Educate healthcare providers about prevention and evidence-based treatment
- Develop sustainable prevention, treatment, and recovery models and payment approaches
- Inform State and Federal policies to ensure access to care
- Raise public awareness of effective strategies for curtailing the crisis
We look forward to continue developing a strong network of grantees, partners, and collaborators.
Karen A. Scott
Our leadership and staff are renowned experts with the vision and passion to drive our mission forward.
Andrea Barthwell, M.D., DFASAM, Board Chair Medical Director at Encounter Medical Group; Founder and CEO of Two Dreams Chicago
Dr. Barthwell, past president of the American Society of Addition Medicine (ASAM), is Founder of Encounter Medical Group, P.C., and Director at Two Dreams, a comprehensive alcoholism and addiction treatment system. From 2003-2004, she served as Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP).
Adrienne M. Brown, MSW, LMSW
Ms. Brown is a dedicated social services professional with over 30 years of experience in providing high quality support services to diverse communities. She served as a senior administrator at Alcoholics Anonymous World Services for 17 years. Ms. Brown is a certified recovery peer advocate.
H. Westley Clark, M.D., J.D., MPH Dean’s Executive Professor of Public Health at Santa Clara University
Dr. Clark is the former Director of the Center for Substance Abuse Treatment at SAMHSA. He contributed to the 2016 Surgeon General’s Report on Alcohol, Drugs, and Health as a Section Editor for Treatment. Dr. Clark is a Distinguished Fellow of the American Society of Addiction Medicine and is a member of the National Advisory Council of NIDA. He is ABAM certified in Addiction Medicine, is licensed to practice medicine in California, Maryland, Massachusetts, and Michigan, and is also a member of the Washington, DC, Bar.
Lori A. Schechter, J.D. Executive Vice President, Chief Legal Officer & General Counsel at McKesson Corporation
Ms. Schechter is Executive Vice President, Chief Legal Officer & General Counsel for the McKesson Corporation. Previously, she was a litigation partner at Morrison & Foerster where she represented clients in complex litigation and investigations. She was named by the National Law Journal as one of the “Top 50 Female Litigators in the Country.” She currently serves on the Board of the National Center for Youth Law, and previously served on the Board of Legal Aid at Work.
Richard S. Schottenfeld, M.D. Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Howard University College of Medicine
Dr. Schottenfeld is a leading clinical researcher, educator, and developer of drug use clinical programs and services. He has authored more than 125 peer-reviewed publications and has played a key role in the development and expansion of primary care-based treatments for OUD. He is currently the PI of a NIDA-funded Clinical Trials Network study investigating innovative strategies for addressing stigma and expanding treatment and recovery services in urban, poor, and minority communities.
Peter Slone Senior Vice President of Corporate Public Affairs at McKesson Corporation
Mr. Slone has been Senior Vice President of Corporate Public Affairs at the McKesson Corporation since June 2015. Previously, he was Vice President of Global Government Affairs at Medtronic plc, where he served for over 13 years.
Adam Usdan President of Trellus Management Corporation LLC
Mr. Usdan has been in the investment advisory industry for over 32 years, founding Trellus Partners in 1994. Mr. Usdan began his investment career in 1987 at Odyssey Partners, where he was responsible for managing long/short U.S. equity. He currently serves on the Boards of Griffin Mining, Wesleyan University, The Jewish Board for Children and Family Services, and The Jonas Center for Nursing and Veterans Healthcare.
FORE was started with a gift from the McKesson Corporation.